 The standard treatment for metastatic cholangiocarcinoma is combination chemotherapy with gemcitabine and cisplatin. The FDA the U.S. Food and Drug Administration has not approved dasatinib for your specific disease Cholangiocarcinoma but it has been approved for other uses Chronic Myeloid Leukemia 